跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
AMPHOTERICIN LIPOSOMAL RBX amphotericin B (amphotericin) 50mg powder for injection vial
Approved
STANDARD
AMPHOTERICIN LIPOSOMAL RBX amphotericin B (amphotericin) 50mg powder for injection vial
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
21bf76f938f709e6
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
21bf76f938f709e6
Product Name
AMPHOTERICIN LIPOSOMAL RBX amphotericin B (amphotericin) 50mg powder for injection vial
Artg Id
380965
Artg Name
AMPHOTERICIN LIPOSOMAL RBX amphotericin B (amphotericin) 50mg powder for injection vial
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2023-03-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
21bf76f938f709e6
Type
Standard
Back to TGA Approvals
AMPHOTERICIN LIPOSOMAL RBX amphotericin B (amphotericin) 50mg powder for injection vial - TGA Drug Approval Details
